Ocugen Inc.

Last updated September 27, 2026

Organization details

Legal name
Ocugen Inc.
Former names
Histogenics Corp
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Delaware
Headquarters city
Malvern
Headquarters state / province
Pennsylvania
Headquarters country
United States
Fiscal year end
December
Ticker symbol
OCGN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001372299

Board of directors

Chief executives

Shankar Musunuri · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

2 of this board's directors also sit on 2 other boards.

Network of Ocugen Inc.'s board connections ACV Auctions Inc. ACV Auctions Inc. Phillips 66 Phillips 66 Kirsten Castillo Kirsten Castillo Marna C. Whittington Marna C. Whittington Ocugen Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$25,830
1 purchase by 1 insider
Sold, last 12 months
$1,088,801
4 sales by 1 insider
Date Insider Transaction Shares Price Value
Oct 9, 2026 Shankar Musunuri Director, Officer (Chief Executive Officer) Open-market sale −468,727 $0.95 $445,291
Oct 9, 2026 Shankar Musunuri Director, Officer (Chief Executive Officer) Open-market sale −57,264 $0.95 $54,401
Sep 9, 2026 Shankar Musunuri Director, Officer (Chief Executive Officer) Open-market sale −468,727 $1.12 $524,974
Sep 9, 2026 Shankar Musunuri Director, Officer (Chief Executive Officer) Open-market sale −57,264 $1.12 $64,136
Jun 15, 2026 Johnson-Greene Treerita Essalima Officer (Chief Financial Officer) Open-market purchase +21,000 $1.23 $25,830
Apr 1, 2026 Junge Zhang Director Option exercise +15,000 $0.51 $7,650
Apr 1, 2026 Junge Zhang Director Option exercise +112,205 $0.46 $51,614
Apr 1, 2026 Junge Zhang Director Option exercise +66,929 $1.42 $95,039
Jan 2, 2026 Shankar Musunuri Director, Officer (Chief Executive Officer) Grant or award +3,123,201 — —
Jan 2, 2026 Ramachandran Ramesh Officer (Chief Accounting Officer) Grant or award +207,300 — —
Jan 3, 2025 Upadhyay Arun Officer (See Remarks) Shares withheld for tax −41,633 $0.89 $37,053
Jan 3, 2025 Shankar Musunuri Director, Officer (Chief Executive Officer) Shares withheld for tax −177,146 $0.89 $157,660
Nov 26, 2024 Prabhavathi Fernandes Director Open-market purchase +10,000 $0.91 $9,100
Nov 22, 2024 Kirsten Castillo Director Open-market purchase +25,000 $0.91 $22,750
Sep 16, 2024 Upadhyay Arun Officer (See Remarks) Shares withheld for tax −842 $1.17 $985

Organizations in the same sector, closest in location and size first.

Questions about Ocugen Inc.

Who is the CEO of Ocugen Inc.?

Shankar Musunuri is Ocugen Inc.'s Chief Executive Officer.

How many directors are on Ocugen Inc.'s board?

Ocugen Inc.'s board has 9 directors: Blaise Coleman, Junge Zhang, Kirsten Castillo, Marna C. Whittington, Prabhavathi Fernandes, Ramesh Kumar, Satishchandran Chandrasekhar, Shankar Musunuri and Uday Kompella.

Are Ocugen Inc. insiders buying or selling shares?

Over the last 12 months, Ocugen Inc. insiders bought $25,830 of shares in 1 purchase and sold $1.1 million of shares in 4 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="ocugen-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.